ML20011A250
| ML20011A250 | |
| Person / Time | |
|---|---|
| Issue date: | 10/02/1981 |
| From: | Sreniaswki D NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION III) |
| To: | |
| Shared Package | |
| ML20011A244 | List: |
| References | |
| NUDOCS 8110080371 | |
| Download: ML20011A250 (2) | |
Text
I Appendix A NOTICE OF VIOLATION Research Medical Center License No. 24-17998-01 License No. 24-18625-01 As a result of the inspection conducted on September 17, 1981, and in accordance with the Interim Enforcement Policy, 45 FR 66754 (October 7, 1980), the following violations were identified:
For License No. 24-17998-01 (Teletherapy):
1.
10 CFR 35.22(a) states that any licensee authorized to use teletherapy units for treating humans shall cause spot-check measurements to be performed on each teletherapy unit at intervals not exceeding one month.
Contrary to the above, no monthly spot-checks were performed between January 26 and March 18, 1981 or April 14 and July 16, 1981.
This is a Severity Level V violation (Supplement VII).
2.
License Condition 26.A. states that each teletherapy room shall be equipped with a radiation zonitoring device which continuously monitors the teletherapy beam condition and is equipped with a back-up battery power supply for emergency operation.
Contrary to the above, your teletherapy room is not equipped with a back-up battery power supply for emergency operation of your radiation monitoring device.
This is a Severity Level V violation (Supplement VII).
3.
License Condition 14.A. states that teletherapy sources shall be tested for leakage at intervals not to exceed six months.
Contrary to the above, your cobalt-60 teletherapy source was not tested for leakage between May 30, 1980 and May 6, 1981, a period exceeding the six month interval required.
This is ' Severity Level V violation (Supplcment VII).
8110080371 811002~
NMS LIC30 24-17998-01 PDR
d Appendix A For License No. 24-18625-01:
4.
License Condition 18 states that the licensee shall possess and use licensed material in accordance with statements, representations and procedures listed in application dated November 22, 1978 and referenced letters.
This application states that your dose calibrator will be calibrated in accordance with Regulatory Guide 10.8, Appendix D, Section 2, which requires daily tests for constancy.
Contrary to the above, no daily constancy tests were performed between June 2 and August 13, 1981, August 20 and 27, 1981, Septemb er 1 and 8, 1981, nor on several other occassions.
This is a Severity Level V violation (Supplement VII).
5.
License Condition 18 states that the licensee shall possess and use licensed material in accordance with statements, representations and procedures listed in application dated November 22, 1978 and referenced letters.
This application states that GM radiation area surveys will be performed daily in dose preparation and administration areas, and weekly in all laboratory areas.
In addition, weekly wipe tests for removable contam-ination are required in all labs.
Contrary to the above, from statements of licensee representatives and a review of available records, no GM or wipe surveys were performed between May and September, 1981 in Scan Rooms 1 and 3, nor between July and September, 1981 in Scan Room 2.
This is a Severity Level V violation (Supplement VII).
Pursuant to the provision = o' 10 CFR 2.201, you are required to submit to this office within thirty days of the date of this Notice a written statement or explanation in reply, including for each item of noncompliance:
(1) cor-rective action taken and the results achieved; (2) corrective action to be taken to avoid further noncompliance; and (3) the date when full compliance will be achieved. Under the authority of Section 182 of the Atomic Energy Act of 1954, as amended, this response shall be submitted under oath or affirmation. Consideration may be given to extending your response time for good cause shown.
/.
/
f.
~)<
Dated _/0"1*Sl D. J. Sreniawski, Chief Materials Radiation Protection Section 2